These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1487160)

  • 1. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy.
    Heresbach D; Raoul JL; Bretagne JF; Minet J; Donnio PY; Ramée MP; Siproudhis L; Gosselin M
    Gut; 1992 Dec; 33(12):1608-11. PubMed ID: 1487160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
    Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
    Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.
    Voutilainen M; Sokka T; Juhola M; Farkkilä M; Hannonen P
    Scand J Gastroenterol; 1998 Aug; 33(8):811-6. PubMed ID: 9754727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.
    Goggin PM; Collins DA; Jazrawi RP; Jackson PA; Corbishley CM; Bourke BE; Northfield TC
    Gut; 1993 Dec; 34(12):1677-80. PubMed ID: 8282254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.
    McCarthy DM
    Scand J Gastroenterol Suppl; 1991; 187():91-7. PubMed ID: 1775931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.
    Frezza M; Gorji N; Melato M
    J Clin Pathol; 2001 Jul; 54(7):521-5. PubMed ID: 11429423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
    Huang JQ; Sridhar S; Hunt RH
    Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly.
    Pilotto A; Franceschi M; Leandro G; Di Mario F; Valerio G
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):951-6. PubMed ID: 9391783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ
    Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    Ji KY; Hu FL
    World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
    Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
    J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term anti-inflammatory drug use and Helicobacter pylori infection: a clinical, endoscopic and histological study.
    Kulkarni SG; Parikh SS; Borges NE; Phadke AY; Desai SB; Vora IM; Kalro RH
    Indian J Gastroenterol; 1996 Oct; 15(4):118-21. PubMed ID: 8916573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection increases the risk of peptic ulcers in chronic users of non-steroidal anti-inflammatory drugs.
    Li EK; Sung JJ; Suen R; Ling TK; Leung VK; Hui E; Cheng AF; Chung S; Woo J
    Scand J Rheumatol; 1996; 25(1):42-6. PubMed ID: 8774555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric emptying of solids in long-term NSAID users: correlation with endoscopic findings and Helicobacter pylori status.
    Kulkarni SG; Parikh SS; Shankhpal PD; Desai SA; Borges NE; Desai SB; Vora IM; Kalro RH
    Am J Gastroenterol; 1999 Feb; 94(2):382-6. PubMed ID: 10022633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Helicobacter pylori and NSAID gastropathy.
    Lazzaroni M; Bianchi Porro G
    Aliment Pharmacol Ther; 2001 Jun; 15 Suppl 1():22-7. PubMed ID: 11488658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.